Contact Us

  • Suzhou Health Chemicals Co., Ltd.
  • Tel : +86-512-58277800
  • FAX : +86-512-58999904
  • Address : No. 338, Jingang Avenue, ZhangJiaGang City, Jiangsu Province, China.
  • P.C. : 215600
  • Email : sales@healthchems.com; sales@healthchemicals.com; healthchemicals@gmail.com
  • QQ : 3204448574
  • Skype : healthchemicals

ProductsDetails

Product Name:
(3S)-5-Fluoro-3-methyl-1(3H)-isobenzofuranone
CAS No:
1803573-19-4
EC No:
943-180-4
Synonyms:
(S)-5-fluoro-3-methylisobenzofuran-1(3H)-one;(S)-3,5-dimethylisobenzofuran-1(3H)-one;(3S)-5-fluoro-3-methyl-1,3-dihydro-2-benzofuran-1-one;1(3H)-Isobenzofuranone, 5-fluoro-3-methyl-, (3S)-;(S)-5-fluoro-3-met ylisobenzofuran-1(3 )-one;6-(S)-5-fluoro-3-methylisobenzofuran-1(3H)-one;(S)-5-Fuoro-3-methylisobenzofuran-1(3H)-one (3S)-5-Fluoro-3-methyl-1(3H)-isobenzofuranone,1803573-19-4,Lorlatinib intermediate,Lorlatinib chiral building block,CAS 1803573-19-4,chiral isobenzofuranone derivative,ALK inhibitor intermediate,ROS1 inhibitor intermediate,NSCLC targeted therapy intermediate,anticancer pharmaceutical intermediate,chiral phthalide core,high purity 99.0 HPLC,Lorlatinib key starting material,oncology drug building blocks,fluorinated chiral lactone,Suzhou Health Chemicals Co Ltd supplier,bulk pharmaceutical intermediate,commercial scale Lorlatinib raw material,custom synthesis 1803573-19-4,API synthesis building block (3S)-5-Fluoro-3-methyl-1(3H)-isobenzofuranone,1803573-19-4,Lorlatinib intermediate,chiral is

Product Introduction

(3S)-5-Fluoro-3-methyl-1(3H)-isobenzofuranone serves as an essential chiral synthetic building block and critical regulatory intermediate in oncology medicinal chemistry, primarily utilized in the synthesis of Lorlatinib, a highly potent third-generation anaplastic lymphoma kinase (ALK) and c-ros oncogene 1 (ROS1) receptor tyrosine kinase inhibitor. Its rigid fluorinated chiral phthalide core efficiently establishes the stereospecific pharmacophore necessary to combat resistance mutations (such as G1202R) encountered in non-small cell lung cancer (NSCLC) treatments and to improve central nervous system penetration against brain metastases. The substance is widely applied in pharmaceutical scale-up route optimization, commercial active pharmaceutical ingredient (API) manufacturing, impurity reference profiling, and medicinal discovery programs targeting novel tyrosine kinase inhibitors.



If you would like to make an inquiry or learn more about the products, please fill in the following form, we will reply in 24 hours.

  • Company:
  • *Name:
  • *E-mail:
  • Tel:
  • Country:
  • *Content:
  •